lymphoma, small lymphocytic
Showing 1 - 17 of 17
Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,
Not yet recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- +5 more
- Nemtabrutinib
- +2 more
- (no location specified)
Jul 21, 2023
Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Small Lymphocytic Trial in United States (JCAR017 (lisocabtagene maraleucel),
Active, not recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- Lymphoma, Small Lymphocytic
- JCAR017 (lisocabtagene maraleucel)
- +2 more
-
Birmingham, Alabama
- +63 more
Nov 21, 2022
Tumors, Leukemia, Lymphocytic, Chronic, Lymphoma, Small Lymphocytic Trial in Victoria (Intermittent fast)
Active, not recruiting
- Neoplasms
- +5 more
- Intermittent fast
-
Victoria, British Columbia, CanadaEleah Stringer
Mar 15, 2022
Patients Receiving CAR-20/19-T Cells
Recruiting
- Chronic Lymphocytic Leukemia
- +2 more
- Long-Term Follow-Up of Participants who Received CAR-20/19-T cells
-
Milwaukee, WisconsinFroedtert Hospital & Medical College of Wisconsin
Sep 19, 2021
NHL, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (veltuzumab)
Completed
- NHL
- +17 more
- veltuzumab
-
Savannah, Georgia
- +4 more
Aug 12, 2021
Lymphoma, Small Lymphocytic, Lymphoma, Lymphoma, Non-Hodgkin Trial in United States (duvelisib, PI3K inhibitor)
Terminated
- Lymphoma, Small Lymphocytic
- +4 more
- duvelisib
- PI3K inhibitor
-
Little Rock, Arkansas
- +10 more
Mar 15, 2021
Lymphocytic Leukemia, Chronic, Lymphoma, Small Lymphocytic Trial in Canada, United States (IPI-145 (duvelisib), Obinutuzumab)
Terminated
- Lymphocytic Leukemia, Chronic
- Lymphoma, Small Lymphocytic
- IPI-145 (duvelisib)
- Obinutuzumab
-
La Jolla, California
- +6 more
Mar 15, 2021
Leukemia, Lymphocytic, Chronic, Lymphoma, Small Lymphocytic Trial in Louisville (Rituximab, Beta-Glucan)
Terminated
- Leukemia, Lymphocytic, Chronic
- Lymphoma, Small Lymphocytic
- Rituximab
- Beta-Glucan
-
Louisville, KentuckyJames Graham Brown Cancer Center
Apr 2, 2018
Chronic Lymphocytic Leukemia, Indolent B-cell Lymphomas, Chronic Hepatitis B Trial in Hong Kong (Ibrutinib)
Unknown status
- Chronic Lymphocytic Leukemia
- +6 more
-
Hong Kong, Hong KongThe University of Hong Kong
Apr 11, 2018
Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic Trial in Ann Arbor, Rochester (Pacritinib, Ibrutinib)
Withdrawn
- Chronic Lymphocytic Leukemia
- Lymphoma, Small Lymphocytic
-
Ann Arbor, Michigan
- +1 more
Sep 5, 2017
Diffuse, Large B-Cell, Lymphoma, Lymphoma, Low-Grade, T-Cell Lymphoma Trial in Boston (Busulfan (conditioning for AUTO
Completed
- Diffuse, Large B-Cell, Lymphoma
- +6 more
- Busulfan (conditioning for AUTO transplant)
- +11 more
-
Boston, Massachusetts
- +1 more
Jan 19, 2017
Lymphoma, Small Lymphocytic, Lymphocytic Leukemia, Chronic Trial in Columbus (Fludarabine, Rituximab, Alemtuzumab)
Completed
- Lymphoma, Small Lymphocytic
- Lymphocytic Leukemia, Chronic
- Fludarabine
- +2 more
-
Columbus, OhioOhio State University
Feb 6, 2017
Lymphoma, Low-Grade, Lymphoma, Small Lymphocytic, Lymphoma, Mixed-Cell, Follicular Trial in United States (Pixantrone (BBR
Completed
- Lymphoma, Low-Grade
- +3 more
- Pixantrone (BBR 2778)
- +3 more
-
Tucson, Arizona
- +3 more
Jan 15, 2015
Leukemia, Lymphocytic, Chronic, B-Cell, Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic Trial in Atlanta
Terminated
- Leukemia, Lymphocytic, Chronic, B-Cell
- +2 more
- Lenalidomide, Rituximab, and Cyclophosphamide
-
Atlanta, GeorgiaEmory University Winship Cancer Institute
Aug 12, 2014
Lymphoma, Small Lymphocytic, Leukemia, Lymphocytic, Chronic Trial in Durham (cenersen sodium, Rituximab, Cyclophosphamide)
Terminated
- Lymphoma, Small Lymphocytic
- Leukemia, Lymphocytic, Chronic
- cenersen sodium
- +3 more
-
Durham, North CarolinaDuke University Medical Center
Nov 26, 2012
Lymphoma, Follicular, Lymphoma, Small Lymphocytic Trial in Houston (autologous human tumor-derived HSPPC-96)
Completed
- Lymphoma, Follicular
- Lymphoma, Small Lymphocytic
- autologous human tumor-derived HSPPC-96
-
Houston, TexasM.D. Anderson Cancer Center
Sep 6, 2012
Leukemia, Lymphocytic, Chronic, Lymphoma, Small Lymphocytic Trial in New York (Pivanex)
Terminated
- Leukemia, Lymphocytic, Chronic
- Lymphoma, Small Lymphocytic
-
New York, New YorkCenter for Lymphoma and Myeloma; Weill Medical College of Cornel
Aug 26, 2005